Zobrazeno 1 - 1
of 1
pro vyhledávání: '"B J Chyla"'
Autor:
Christopher J. Walker, Denis-Claude Roy, B J Chyla, G. Marcucci, Joshua J. Oaks, Jason G. Harb, Paolo Neviani, Peter Hokland, Justin Ellis, Michael A. Caligiuri, Claudia S. Huettner, Gregory Ferenchak, Danilo Perrotti
Publikováno v:
Harb, J G, Neviani, P, Chyla, B J, Ellis, J J, Ferenchak, G J, Oaks, J J, Walker, C J, Hokland, P, Roy, D, Caligiuri, M A, Marcucci, G, Huettner, C S & Perrotti, D 2013, ' Bcl-xL anti-apoptotic network is dispensable for development and maintenance of CML but is required for disease progression where it represents a new therapeutic target ', Leukemia, vol. 27, no. 10, pp. 1996-2005 . https://doi.org/10.1038/leu.2013.151
The dismal outcome of blast crisis chronic myelogenous leukemia (CML-BC) patients underscores the need for a better understanding of the mechanisms responsible for the development of drug resistance. Altered expression of the anti-apoptoticBcl-xL has
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9010501d516f048c6353c6e29f4345a8
https://pure.au.dk/portal/da/publications/bclxl-antiapoptotic-network-is-dispensable-for-development-and-maintenance-of-cml-but-is-required-for-disease-progression-where-it-represents-a-new-therapeutic-target(a3d9e9d9-3948-494f-9efa-746d18dd6ade).html
https://pure.au.dk/portal/da/publications/bclxl-antiapoptotic-network-is-dispensable-for-development-and-maintenance-of-cml-but-is-required-for-disease-progression-where-it-represents-a-new-therapeutic-target(a3d9e9d9-3948-494f-9efa-746d18dd6ade).html